Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on changes in ambulatory blood pressure: a sub-analysis of a randomized clinical trial - Takeaways - MDSpire

Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on changes in ambulatory blood pressure: a sub-analysis of a randomized clinical trial

  • By

  • Ana María Gómez-Pérez

  • Borja Bandera-Merchán

  • José Ignacio Martínez-Montoro

  • Mario Gutiérrez-Bedmar

  • Cristina Díaz-Perdigones

  • Alba Subiri-Verdugo

  • Isabel Moreno-Indias

  • Francisco J Tinahones

  • September 5, 2025

  • 0 min

Share

  • 1

    Obesity significantly contributes to hypertension, necessitating effective dietary interventions for weight loss and blood pressure management.

  • 2

    In a randomized trial, modified alternate-day fasting (mADF) showed the greatest improvements in 24-hour ambulatory blood pressure monitoring among various diets.

  • 3

    All dietary interventions improved anthropometric parameters, but only mADF and evening time-restricted eating (lTRE) demonstrated significant blood pressure changes.

  • 4

    Diets with varying ketogenic potential can effectively reduce blood pressure in obese individuals, with mADF being the most effective approach.

  • 5

    Changes in body fat were linked to reductions in blood pressure, while age and sex did not significantly influence these outcomes.

Original Source(s)

Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on changes in ambulatory blood pressure: a sub-analysis of a randomized clinical trial

  • by Ana María Gómez-Pérez, Borja Bandera-Merchán, José Ignacio Martínez-Montoro, Mario Gutiérrez-Bedmar, Cristina Díaz-Perdigones, Alba Subiri-Verdugo, Isabel Moreno-Indias, Francisco J Tinahones

  • September 5, 2025

Related Content

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

School-Based Screening Detected Undiagnosed Hypertension

Novel program enabled large-scale blood pressure screening and identified elevated readings in community setting.

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.